Holding(s) in Company
Spreadex LTD has acquired a new major holding in Proteome Sciences PLC, crossing a threshold on January 30, 2026. The notification, dated February 2, 2026, reveals that Spreadex LTD now holds 1.5015% of voting rights attached to shares, amounting to 5,266,100 shares, and an additional 1.6293% through financial instruments, specifically CFDs/Spread Bets, representing 5,714,286 voting rights. This brings Spreadex LTD's total position to 3.1308% of the total 10,980,386 voting rights in the issuer.
Select text to share a quote on X · sign in to keep highlights & notes in your PRM notes
Issuer Details
ISIN
GB0003104196
Issuer Name
PROTEOME SCIENCES PLC
UK or Non-UK Issuer
UK
- Reason for Notification
- Details of person subject to the notification obligation
Name
Spreadex LTD
City of registered office (if applicable)
Albans
Country of registered office (if applicable)
United Kingdom
Details of the shareholder
City of registered office (if applicable)
Country of registered office (if applicable)
Date on which the threshold was crossed or reached
30-Jan-2026
Date on which Issuer notified
02-Feb-2026
- Total positions of person(s) subject to the notification obligation
Position of previous notification (if applicable)
Voting rights attached to shares
| GB0003104196 | 5,266,100 | 1.5015 |
| Sub Total 8.A | 5,266,100 | 1.5015% |
| 8B1. Financial Instruments according to (DTR5.3.1R.(1) (a)) | ||
| CFD/Spread Bet | 5,714,286 | 1.6293 |
| Sub Total 8.B1 | 5,714,286 | 1.6293% |
- Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Sub Total 8.B2
- Information in relation to the person subject to the notification obligation
- In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional Information
Lawson Roberts
Date of Completion
02-Feb-2026
Place Of Completion
United Kingdom
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.